Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040773045> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2040773045 abstract "Aims: U.S. prescription drug use is common, second only to marijuana use. Kentucky continues with high rates of non-medical prescription use, particularly prescription opioids in Appalachian Kentucky. Prescription opioid abuse is associated with increasing arrests. However, there is little systematic examination of prescriptionopioiduse in criminal justice settings. The aimof this study is to examine prescription opioid use levels among Kentucky prisoners to understand other drug use and related behavior. Methods: The ASSIST and TCU Drug Screeners were administered to 337 prisoners. After consent, subjects entered protocols as part of the NIDA CJDATS 2 cooperative agreement. Analysis examined past 3 month drug use and problem behaviors for 3 levels of prescription opioid use: daily (n=86), some (n=91) and none (n=160). ANCOVA and logistic regressions were performed controlling for group differences in age, gender, race, and rural residence. Results: Daily prescription opioid users were younger (34.2), more female (39.5%), more white (90.7%) and more rural (58.5%). Daily users significantly reported more use of prescription sedatives (71.3% vs. 56% and 15%, p=< .000) than those in the no use or some use categories. There were no differences in other drug use patterns except for those who reported some use of prescription stimulants (p=< .003) and hallucinogens (p=< .035). Daily users weremore likely to inject drugs, rate their druguse asmore serious, rate themselves asmore dependent on drugs, and report that treatment is important. However, there was no difference in previous treatment history. Conclusions: Findings suggest that daily users of prescription opioids in the criminal justice system are at greater risk for additional substanceuseand relatedproblems. Theyarealsomore likely to report the importance of treatment. Implications for treatment planning, community re-entry and treatment will be discussed. Financial support: CJDATS 2 is funded by NIDA in collaboration with SAMSHA and DOJ." @default.
- W2040773045 created "2016-06-24" @default.
- W2040773045 creator A5001078074 @default.
- W2040773045 creator A5003380925 @default.
- W2040773045 creator A5028114642 @default.
- W2040773045 creator A5032814769 @default.
- W2040773045 creator A5033252700 @default.
- W2040773045 creator A5041974032 @default.
- W2040773045 creator A5082659469 @default.
- W2040773045 date "2014-07-01" @default.
- W2040773045 modified "2023-09-27" @default.
- W2040773045 title "Prescription opioid abuse and related behavior among prisoners" @default.
- W2040773045 doi "https://doi.org/10.1016/j.drugalcdep.2014.02.342" @default.
- W2040773045 hasPublicationYear "2014" @default.
- W2040773045 type Work @default.
- W2040773045 sameAs 2040773045 @default.
- W2040773045 citedByCount "0" @default.
- W2040773045 crossrefType "journal-article" @default.
- W2040773045 hasAuthorship W2040773045A5001078074 @default.
- W2040773045 hasAuthorship W2040773045A5003380925 @default.
- W2040773045 hasAuthorship W2040773045A5028114642 @default.
- W2040773045 hasAuthorship W2040773045A5032814769 @default.
- W2040773045 hasAuthorship W2040773045A5033252700 @default.
- W2040773045 hasAuthorship W2040773045A5041974032 @default.
- W2040773045 hasAuthorship W2040773045A5082659469 @default.
- W2040773045 hasConcept C118552586 @default.
- W2040773045 hasConcept C126322002 @default.
- W2040773045 hasConcept C170493617 @default.
- W2040773045 hasConcept C2426938 @default.
- W2040773045 hasConcept C2779418921 @default.
- W2040773045 hasConcept C2781063702 @default.
- W2040773045 hasConcept C2911204551 @default.
- W2040773045 hasConcept C40010229 @default.
- W2040773045 hasConcept C71924100 @default.
- W2040773045 hasConcept C98274493 @default.
- W2040773045 hasConceptScore W2040773045C118552586 @default.
- W2040773045 hasConceptScore W2040773045C126322002 @default.
- W2040773045 hasConceptScore W2040773045C170493617 @default.
- W2040773045 hasConceptScore W2040773045C2426938 @default.
- W2040773045 hasConceptScore W2040773045C2779418921 @default.
- W2040773045 hasConceptScore W2040773045C2781063702 @default.
- W2040773045 hasConceptScore W2040773045C2911204551 @default.
- W2040773045 hasConceptScore W2040773045C40010229 @default.
- W2040773045 hasConceptScore W2040773045C71924100 @default.
- W2040773045 hasConceptScore W2040773045C98274493 @default.
- W2040773045 hasLocation W20407730451 @default.
- W2040773045 hasOpenAccess W2040773045 @default.
- W2040773045 hasPrimaryLocation W20407730451 @default.
- W2040773045 hasRelatedWork W1759302284 @default.
- W2040773045 hasRelatedWork W1963948425 @default.
- W2040773045 hasRelatedWork W2036705864 @default.
- W2040773045 hasRelatedWork W2117588721 @default.
- W2040773045 hasRelatedWork W2126617768 @default.
- W2040773045 hasRelatedWork W2173720074 @default.
- W2040773045 hasRelatedWork W2345564050 @default.
- W2040773045 hasRelatedWork W2583167486 @default.
- W2040773045 hasRelatedWork W2792931278 @default.
- W2040773045 hasRelatedWork W2849618949 @default.
- W2040773045 hasRelatedWork W2888011568 @default.
- W2040773045 hasRelatedWork W2914734409 @default.
- W2040773045 hasRelatedWork W2915653773 @default.
- W2040773045 hasRelatedWork W2942713474 @default.
- W2040773045 hasRelatedWork W2959224618 @default.
- W2040773045 hasRelatedWork W2975859946 @default.
- W2040773045 hasRelatedWork W2985001984 @default.
- W2040773045 hasRelatedWork W3202099911 @default.
- W2040773045 hasRelatedWork W2475266518 @default.
- W2040773045 hasRelatedWork W3086676913 @default.
- W2040773045 isParatext "false" @default.
- W2040773045 isRetracted "false" @default.
- W2040773045 magId "2040773045" @default.
- W2040773045 workType "article" @default.